scholarly journals Origin, trafficking, and intraepithelial fate of gut-tropic T cells

2013 ◽  
Vol 210 (9) ◽  
pp. 1839-1854 ◽  
Author(s):  
Delphine Guy-Grand ◽  
Pierre Vassalli ◽  
Gerard Eberl ◽  
Pablo Pereira ◽  
Odile Burlen-Defranoux ◽  
...  

The small intestine epithelium (SI-Ep) harbors millions of unconventional (γδ and CD4− CD8− NK1.1− TCRαβ) and conventional (CD8αβ and CD4) T cells, designated intraepithelial lymphocytes (IELs). Here, we identified the circulating pool of SI-Ep–tropic T cells and studied their capacity to colonize the SI-Ep under steady-state conditions in SPF mice. Developmentally regulated levels of α4β7 endowed recent thymic emigrants (RTEs) of unconventional types with higher SI-Ep tropism than their conventional homologues. SI-Ep–tropic RTEs, which in all lineages emerged naive, homed to the SI-Ep, but this environment was inadequate to stimulate them to cycle. In contrast, conventional and, unexpectedly, unconventional T cells, particularly Vγ7+ (hallmark of γδ IELs), previously stimulated to cycle in the gut-associated lymphoid tissue (GALT), proliferated in the SI-Ep. Cycling unconventional SI-Ep immigrants divided far more efficiently than their conventional homologues, thereby becoming predominant. This difference impacted on acquisition of high Granzyme B content, which required extensive proliferation. In conclusion, SI-Ep–tropic T cells follow a thymus–SI-Ep or a GALT–SI-Ep pathway, the latter generating highly competitive immigrants that are the sole precursors of cytotoxic IELs. These events occur continuously as part of the normal IEL dynamics.

Author(s):  
Weiming Yang ◽  
Weiheng Zhang ◽  
Xiaozhong Wang ◽  
Liming Tan ◽  
Hua Li ◽  
...  

Background: The antigen HCA587 (also known as MAGE-C2), which is considered a cancer-testis antigen, exhibits upregulated expression in a wide range of malignant tumors with unique immunological properties, and may thus serve as a promising target for tumor immunotherapy. Objective: To explore the antitumor effect of the HCA587 protein vaccine and the response of humoral and cell-mediated immunity. Methods: The HCA587 protein vaccine was formulated with adjuvants CpG and and ISCOM. B16 melanoma cells were subcutaneously inoculated to C57BL/6 mice, followed by treatment with HCA587 protein vaccine subcutaneously. Mouse survival was monitored daily, and tumor volume was measured every 2 to 3 days. The tumor sizes, survival time and immune cells in tumor tissues were detected. And the vital immune cell subset and effector molecules were explored. Results: After treatment with HCA587 protein vaccine, the vaccination generated elicited significant immune responses, which delayed tumor growth and improved animal survival. The vaccination increased the proportion of CD4+ T cells expressing IFN-γ and granzyme B in tumor tissues. Depletion of CD4+T cells resulted in an almost complete abrogation of the antitumor effect of the vaccination, suggesting that the antitumor efficacy was mediated by CD4+ T cells. In addition, knockout of IFN-γ resulted in a decrease in granzyme B levels which were secreted by CD4+ T cells, and the antitumor effect was also significantly attenuated. Conclusion: The HCA587 protein vaccine may increase the levels of granzyme B expressed by CD4+ T cells, and this increase is dependent on IFN-γ, and the vaccine resulted in a specific tumor immune response and subsequent eradication of the tumor.


Author(s):  
Katherine A Richards ◽  
Maryah Glover ◽  
Jeremy C Crawford ◽  
Paul Thomas ◽  
Chantelle White ◽  
...  

Abstract Repeated infections with endemic human coronaviruses are thought to reflect lack of long-lasting protective immunity. Here, we evaluate circulating human CD4 T cells collected prior to 2020 for reactivity towards hCoV spike proteins, probing for the ability to produce IFN-γ, IL-2 or granzyme B. We find robust reactivity to spike-derived epitopes, comparable to influenza, but highly variable abundance and functional potential across subjects, depending on age and viral antigen specificity. To explore the potential of these memory cells to be recruited in SARS-CoV-2 infection, we examined the same subjects for cross-reactive recognition of epitopes from SARS-CoV-2 nucleocapsid, membrane/envelope, and spike. The functional potential of these cross-reactive CD4 T cells was highly variable, with nucleocapsid-specific CD4 T cells, but not spike-reactive cells showing exceptionally high levels of granzyme production upon stimulation. These results are considered in light of recruitment of hCoV-reactive cells into responses of humans to SARS-CoV infections or vaccinations.


2006 ◽  
Vol 18 (3) ◽  
pp. 415-423 ◽  
Author(s):  
Alexandra Rizzitelli ◽  
Edwin Hawkins ◽  
Hilary Todd ◽  
Philip D. Hodgkin ◽  
Ken Shortman

Cell Reports ◽  
2015 ◽  
Vol 12 (10) ◽  
pp. 1555-1563 ◽  
Author(s):  
Nicole L.K. Galloway ◽  
Gilad Doitsh ◽  
Kathryn M. Monroe ◽  
Zhiyuan Yang ◽  
Isa Muñoz-Arias ◽  
...  

2011 ◽  
Vol 7 (12) ◽  
pp. e1002396 ◽  
Author(s):  
Jeffrey Pido-Lopez ◽  
William W. Kwok ◽  
Timothy J. Mitchell ◽  
Robert S. Heyderman ◽  
Neil A. Williams

2007 ◽  
Vol 178 (11) ◽  
pp. 6931-6940 ◽  
Author(s):  
Sabine Classen ◽  
Thomas Zander ◽  
Daniela Eggle ◽  
Jens M. Chemnitz ◽  
Benedikt Brors ◽  
...  
Keyword(s):  
T Cells ◽  

Epilepsia ◽  
2009 ◽  
Vol 50 (6) ◽  
pp. 1419-1431 ◽  
Author(s):  
Yukitoshi Takahashi ◽  
Jyun Mine ◽  
Yuko Kubota ◽  
Etsuko Yamazaki ◽  
Tateki Fujiwara

2016 ◽  
Vol 150 (4) ◽  
pp. S578
Author(s):  
Jonathan Jacobs ◽  
Lin Lin ◽  
Venu Lagishetty ◽  
Paul Ruegger ◽  
James Borneman ◽  
...  
Keyword(s):  
T Cells ◽  

2018 ◽  
Vol 14 (8) ◽  
pp. e1007269 ◽  
Author(s):  
Dorota Kmiec ◽  
Bengisu Akbil ◽  
Swetha Ananth ◽  
Dominik Hotter ◽  
Konstantin M. J. Sparrer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document